These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 29915347)

  • 1. Comparative Evaluation of MS-based Metabolomics Software and Its Application to Preclinical Alzheimer's Disease.
    Hao L; Wang J; Page D; Asthana S; Zetterberg H; Carlsson C; Okonkwo OC; Li L
    Sci Rep; 2018 Jun; 8(1):9291. PubMed ID: 29915347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Community-Based Study Identifying Metabolic Biomarkers of Mild Cognitive Impairment and Alzheimer's Disease Using Artificial Intelligence and Machine Learning.
    Yilmaz A; Ustun I; Ugur Z; Akyol S; Hu WT; Fiandaca MS; Mapstone M; Federoff H; Maddens M; Graham SF
    J Alzheimers Dis; 2020; 78(4):1381-1392. PubMed ID: 33164929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Widely targeted metabolomics of Alzheimer's disease postmortem cerebrospinal fluid based on 9-fluorenylmethyl chloroformate derivatized ultra-high performance liquid chromatography tandem mass spectrometry.
    Muguruma Y; Tsutsui H; Noda T; Akatsu H; Inoue K
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Aug; 1091():53-66. PubMed ID: 29852382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward a predictive model of Alzheimer's disease progression using capillary electrophoresis-mass spectrometry metabolomics.
    Ibáñez C; Simó C; Martín-Álvarez PJ; Kivipelto M; Winblad B; Cedazo-Mínguez A; Cifuentes A
    Anal Chem; 2012 Oct; 84(20):8532-40. PubMed ID: 22967182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of chemical isotope labeling LC-MS for tissue metabolomics and its application for brain and liver metabolome profiling in Alzheimer's disease mouse model.
    Wang X; Han W; Yang J; Westaway D; Li L
    Anal Chim Acta; 2019 Mar; 1050():95-104. PubMed ID: 30661596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study.
    Varma VR; Oommen AM; Varma S; Casanova R; An Y; Andrews RM; O'Brien R; Pletnikova O; Troncoso JC; Toledo J; Baillie R; Arnold M; Kastenmueller G; Nho K; Doraiswamy PM; Saykin AJ; Kaddurah-Daouk R; Legido-Quigley C; Thambisetty M
    PLoS Med; 2018 Jan; 15(1):e1002482. PubMed ID: 29370177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isotope Corrected Chiral and Achiral Nontargeted Metabolomics: An Approach for High Accuracy and Precision Metabolomics Based on Derivatization and Its Application to Cerebrospinal Fluid of Patients with Alzheimer's Disease.
    Takayama T; Mizuno H; Toyo'oka T; Akatsu H; Inoue K; Todoroki K
    Anal Chem; 2019 Apr; 91(7):4396-4404. PubMed ID: 30831026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using direct infusion mass spectrometry for serum metabolomics in Alzheimer's disease.
    González-Domínguez R; García-Barrera T; Gómez-Ariza JL
    Anal Bioanal Chem; 2014 Nov; 406(28):7137-48. PubMed ID: 25230597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of isotope labeling liquid chromatography mass spectrometry for mouse urine metabolomics: quantitative metabolomic study of transgenic mice related to Alzheimer's disease.
    Peng J; Guo K; Xia J; Zhou J; Yang J; Westaway D; Wishart DS; Li L
    J Proteome Res; 2014 Oct; 13(10):4457-69. PubMed ID: 25164377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic Alterations in the Outer Membrane Vesicles of Patients with Alzheimer's Disease: An LC-MS/MS-based Metabolomics Analysis.
    Wei SC; Wei W; Peng WJ; Liu Z; Cai ZY; Zhao B
    Curr Alzheimer Res; 2019; 16(13):1183-1195. PubMed ID: 31755388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma metabolomics in early Alzheimer's disease patients diagnosed with amyloid biomarker.
    Peña-Bautista C; Roca M; Hervás D; Cuevas A; López-Cuevas R; Vento M; Baquero M; García-Blanco A; Cháfer-Pericás C
    J Proteomics; 2019 May; 200():144-152. PubMed ID: 30978462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-resolution metabolomic profiling of Alzheimer's disease in plasma.
    Niedzwiecki MM; Walker DI; Howell JC; Watts KD; Jones DP; Miller GW; Hu WT
    Ann Clin Transl Neurol; 2020 Jan; 7(1):36-45. PubMed ID: 31828981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying Hair Biomarker Candidates for Alzheimer's Disease Using Three High Resolution Mass Spectrometry-Based Untargeted Metabolomics Strategies.
    Chang CW; Hsu JY; Hsiao PZ; Chen YC; Liao PC
    J Am Soc Mass Spectrom; 2023 Apr; 34(4):550-561. PubMed ID: 36973238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new metabolomic workflow for early detection of Alzheimer's disease.
    Ibáñez C; Simó C; Barupal DK; Fiehn O; Kivipelto M; Cedazo-Mínguez A; Cifuentes A
    J Chromatogr A; 2013 Aug; 1302():65-71. PubMed ID: 23827464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic and central nervous system metabolic alterations in Alzheimer's disease.
    van der Velpen V; Teav T; Gallart-Ayala H; Mehl F; Konz I; Clark C; Oikonomidi A; Peyratout G; Henry H; Delorenzi M; Ivanisevic J; Popp J
    Alzheimers Res Ther; 2019 Nov; 11(1):93. PubMed ID: 31779690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood-based diagnosis of Alzheimer's disease using fingerprinting metabolomics based on hydrophilic interaction liquid chromatography with mass spectrometry and multivariate statistical analysis.
    Inoue K; Tsuchiya H; Takayama T; Akatsu H; Hashizume Y; Yamamoto T; Matsukawa N; Toyo'oka T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jan; 974():24-34. PubMed ID: 25463194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-Throughput Metabolomics for Discovering Potential Metabolite Biomarkers and Metabolic Mechanism from the APPswe/PS1dE9 Transgenic Model of Alzheimer's Disease.
    Yu J; Kong L; Zhang A; Han Y; Liu Z; Sun H; Liu L; Wang X
    J Proteome Res; 2017 Sep; 16(9):3219-3228. PubMed ID: 28753016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A metabolomic study based on accurate mass and isotopic fine structures by dual mode combined-FT-ICR-MS to explore the effects of Rhodiola crenulata extract on Alzheimer disease in rats.
    Zhang X; Jiang X; Wang X; Zhao Y; Jia L; Chen F; Yin R; Han F
    J Pharm Biomed Anal; 2019 Mar; 166():347-356. PubMed ID: 30690248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovering Hair Biomarkers of Alzheimer's Disease Using High Resolution Mass Spectrometry-Based Untargeted Metabolomics.
    Su YH; Chang CW; Hsu JY; Li SW; Sung PS; Wang RH; Wu CH; Liao PC
    Molecules; 2023 Feb; 28(5):. PubMed ID: 36903413
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.